CAR T-Cell Therapy Approved for Heavily Pretreated Multiple Myeloma

The FDA approved the chimeric antigen receptor T-cell therapy ciltacabtagene autoleucel, or cilta-cel, (Carvykti, ...

MARCH 1, 2022